Table 1 Baseline characteristics
From: Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study
Reference population in 01 January 1996 | MI population at time of MI | |
|---|---|---|
n | 2,871,168 | 122,275 |
No. of person-years | 40,038,194 | 594,061 |
Female, n (%) | 1,493,795 (52.0) | 47,501 (38.8) |
Median age (IQR) | ||
Men | 49.5 (39.5–61.3) | 59.2 (49.5–69.5) |
Women | 51.7 (41.0–66.4) | 68.5 (58.1–76.0) |
Comorbidity, n (%) | ||
COPD | 37,001 (1.3) | 11,032 (9.0) |
Dyslipidemia | 13,794 (0.5) | 21,408 (17.6) |
Diabetes mellitus | 58,495 (2.0) | 15,154 (12.4) |
Hypertension | 116,249 (4.1) | 17,187 (14.1) |
Medication, n (%) | ||
Aspirin | 121,922 (4.3) | 44,145 (36.1) |
Renin-angiotensin inhibitors | 92,811 (3.2) | 37,562 (30.7) |
Calcium channel blockers | 124,708 (4.3) | 36,787 (30,1) |
Beta blockers | 121,792 (4.2) | 33,771 (27.6) |
Statins | 10,638 (0.4) | 21,200 (17.3) |